Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)

Stopped The study was terminated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns

Conditions

• Post-traumatic Stress Disorder
• PTSD

Interventions

• DRUG: Placebo
• DRUG: Brexpiprazole

Sponsor

H. Lundbeck A/S

Collaborators

• [object Object]